Grigorios Siokas Buys 701,447 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 701,447 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was purchased at an average cost of $0.23 per share, with a total value of $161,332.81. Following the completion of the purchase, the chief executive officer directly owned 13,263,361 shares of the company’s stock, valued at $3,050,573.03. This represents a 5.58% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, June 11th, Grigorios Siokas bought 218,447 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.21 per share, with a total value of $45,873.87.

Cosmos Health Price Performance

NASDAQ:COSM opened at $0.21 on Friday. Cosmos Health Inc. has a 1-year low of $0.20 and a 1-year high of $1.32. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. The firm has a fifty day simple moving average of $0.30 and a 200 day simple moving average of $0.40. The stock has a market capitalization of $13.04 million, a PE ratio of -0.33 and a beta of 4.79.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The business had revenue of $18.40 million during the quarter, compared to analysts’ expectations of $17.93 million. On average, research analysts expect that Cosmos Health Inc. will post -0.06 EPS for the current fiscal year.

Cosmos Health News Roundup

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: The company reported annualized sales above $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, and outlined EU expansion plans that could target $7.4 million in revenue and $5.3 million in gross profit by 2028. Article Title
• Positive Sentiment: Cosmos Health announced new contract manufacturing orders totaling 253,657 units, adding to evidence that its Cana subsidiary is seeing steady commercial demand across multiple medicines and pharmaceutical products. Article Title
• Positive Sentiment: CEO Grigorios Siokas made additional open-market share purchases, which investors often view as a signal of management confidence in the company’s outlook. Article Title
• Positive Sentiment: The company signed a letter of intent to acquire Doc Pharma S.A., a GMP manufacturer, a move that could expand assets, production capacity, margins, and its product portfolio if completed. Article Title

Hedge Funds Weigh In On Cosmos Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC grew its stake in shares of Cosmos Health by 260.5% in the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after buying an additional 241,775 shares in the last quarter. Citadel Advisors LLC grew its stake in shares of Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after buying an additional 128,776 shares in the last quarter. Finally, XTX Topco Ltd grew its stake in shares of Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after buying an additional 34,117 shares in the last quarter. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.